The SingHealth Investigational Medicine Unit is administering the trial for the vaccine.

Called Lunar-Cov19, the vaccine is developed by Duke-NUS Medical School and United States pharmaceutical company Arcturus Therapeutics.

Associate Professor Jenny Low, deputy clinical and scientific director at the SingHealth unit, has told The Straits Times that more than 250 volunteers have stepped forward for the trial.

Around 100 people will take part in the trial. The volunteers are in their 20s to 50s.


“As the trial is open to volunteers from 21 to 80 years old, we continue to be on the lookout for more participants, especially those in the older age group,” she added.